GR

Gandicheruvu Rajini Yadav

Active Director Director DIN 10375323
DIN 10375323 First appointment Oct 2023 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Gandicheruvu Rajini Yadav

Data last updated:

Gandicheruvu Rajini Yadav is a Director at Ashritha Pharma Private Limited (since 2023). The company operates in Paper.

DIN 10375323
Primary Designation Director
Industry Paper
First Appointment 30 Oct 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ashritha Pharma Private Limited U21001TS2023PTC178573
Director30 Oct 20232023Active

Board colleagues of Gandicheruvu Rajini Yadav

NameDINCompanyDesignation
Bramakumarikalyani Gaderaju08140323Ashritha Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ashritha Pharma Private Limited
Premium access

Shareholding and investment profile for Gandicheruvu Rajini Yadav

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gandicheruvu Rajini Yadav

Gandicheruvu Rajini Yadav currently holds 1 directorship: Ashritha Pharma Private Limited (Director, since 30 Oct 2023).

Gandicheruvu Rajini Yadav was first appointed on 30 Oct 2023 as Director at Ashritha Pharma Private Limited.

The current boards of Gandicheruvu Rajini Yadav's companies include Bramakumarikalyani Gaderaju (Ashritha Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available